GL
PMN icon

Graypoint LLC’s ProMIS Neurosciences PMN Stock Holding History

Graypoint LLC’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$25.6K Buy
+2,113
New +$28.8K ﹤0.01% 526

Other funds holding PMN

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return

Graypoint LLC's PMN Position: Q2 2025 in Review

Graypoint LLC opened a new position in ProMIS Neurosciences (PMN) in Q2 2025: 2,113 shares worth $25.6K. The stake represents ﹤0.01% of the portfolio and ranks #526 among its holdings.

19 funds tracked by Wall St. Rank hold PMN as of Q2 2025.

  • Graypoint LLC held 2,113 shares of ProMIS Neurosciences worth $25.6K as of Q2 2025.
  • ProMIS Neurosciences was a new Graypoint LLC position in Q2 2025.
  • ProMIS Neurosciences made up ﹤0.01% of Graypoint LLC's portfolio in Q2 2025, its #526 holding.
  • 19 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.